AMICUS THERAPEUTICS, INC. - Director's Dealing 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-11-04

Reporting Person: Prout Samantha (Principal Accounting Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-04	Common Stock	M	5337	$14.88	Acquired	22472	Direct
2020-11-04	Common Stock	M	594	$10.04	Acquired	23066	Direct
2020-11-04	Common Stock	S	5931	$20.00	Disposed	17135	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-04	Stock Options (right to buy)	$14.88	M	5337	Disposed	2028-03-26	Common Stock (5337)	Direct
2020-11-04	Stock Options (right to buy)	$10.04	M	594	Disposed	2029-01-02	Common Stock (594)	Direct

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: As of November 4, 2020, 5,337 options were fully vested and exercisable and 2,940 remained unvested from this grant.

F3: As of November 4, 2020, 594 options were fully vested and exercisable and 5,148 remained unvested from this grant.